This inventor holds 7 USPTO granted patents. Top assignees: Biopharm (UK) Limited, Merck Patent Gmbh, Biophram (UK) Limited. Active years: 1989-1999.
Location History:
- Swansea, GB (1989 - 1992)
- Llandeilo, GB (1994)
- Dyfed, GB (1995 - 1996)
- Trapp, GB (1999)
Company Filing History:
3 out of 3 
3 out of 3,020 
1 out of 1 
Years Active: 1989-1999
Title: Roy T Sawyer: Innovator in Thrombotic Treatment
Introduction
Roy T Sawyer is a notable inventor based in Dyfed, GB. He has made significant contributions to the field of medical innovations, particularly in the treatment of thrombotic events. With a total of 7 patents to his name, Sawyer's work has the potential to impact patient care and treatment options.
Latest Patents
Among his latest patents is a method for preventing the formation of platelet-rich clots or thrombus, utilizing hementin, a polypeptide derived from leech salivary glands. This innovative approach aims to deaggregate platelet-rich clots, offering a new avenue for treatment. Hementin can be administered in a pharmaceutically acceptable carrier or excipient, with or without additional anticoagulants such as hirudin, hirudin analogues, or an inhibitor of factor Xa. Another significant patent focuses on platelet adhesion inhibitors, further showcasing his expertise in this critical area of medical research.
Career Highlights
Throughout his career, Sawyer has worked with reputable companies, including Biopharm (UK) Limited and Merck Patent GmbH. His experience in these organizations has contributed to his development as a leading inventor in the medical field.
Collaborations
Sawyer has collaborated with notable individuals such as Christopher Powell-Jones and Asgar Electricwala, enhancing his research and innovation efforts.
Conclusion
Roy T Sawyer's contributions to the field of thrombotic treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatment options that could benefit many patients in need.